HitGen Stock Hits Day Low of CNY 26.40 Amid Price Pressure

HitGen, Inc., a midcap player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline today, with its stock price dropping by 6.09% on March 3, 2026. The stock reached an intraday low of CNY 26.40, reflecting a challenging trading session. In terms of performance metrics, HitGen has faced a significant downturn over the past week, with a decrease of 8.74%. The one-month performance shows a decline of 15.32%, contrasting sharply with its impressive one-year performance of 60.98%, which outpaces the China Shanghai Composite's 22.49% gain. Year-to-date, HitGen has managed a positive return of 13.13%, while its three-year performance stands at an impressive 84.88%. Despite the recent volatility, the company has reported strong financial results, including a remarkable net profit growth of 114.98% as of September 25. Key indicators such as operating cash flow and pre-tax profit have also shown significant increases, suggesting a solid operational foundation. However, the stock's five and ten-year performance remains negative, indicating a complex long-term outlook.